Abbott (ABT) Surpasses Q1 Earnings and Revenue Estimates

12:45pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Abbott (ABT) delivered earnings and revenue surprises of 17.69% and 7.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Abbott Laboratories, the maker of the popular rapid BinaxNow COVID-19 test, made $3.3 billion in revenue from its COVID-19 tests in the first three months of the year, far surpassing the $2.5 billion
Abbott Laboratories (NYSE:ABT ) Q1 2022 Earnings Conference Call April 20, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robert
Within Adult Nutrition, Abbott (ABT) gains from the strong performance of Ensure and Glucerna brands in Q1.

Highly Valued Abbot Laboratories Could Move Lower

10:37am, Wednesday, 20'th Apr 2022
Abbott Laboratories (NYSE: ABT) is not in danger of losing its business but we have some concerns its share price could fall. Not only is it a highly-valued stock compared to peers but its current rev
Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade after the Dow Jones jumped around 500 points in the previous session. Investors are awaiting earnings results from The
Abbott Laboratories (NYSE: ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased

5 Stocks To Watch For April 20, 2022

09:02am, Wednesday, 20'th Apr 2022 Benzinga
Some of the stocks that may grab investor focus today are: Wall Street expects The Procter & Gamble Company (NYSE: PG) to report quarterly earnings at $1.30 per share on revenue of $18.73 billion be
Shares of Abbott Laboratories ABT, +3.17% were down 2.0% in premarket trading on Wednesday though the company beat earnings and revenue expectations in the first quarter of 2022, driven in large part
Abbott Laboratories reported a 36% rise in quarterly profit on Wednesday, boosted by an Omicron-led demand for its COVID-19 test kits and a recovery in elective procedures, which boosted demand for it

Why Abbott (ABT) Could Beat Earnings Estimates Again

04:10pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 Things About Abbott Laboratories That Smart Investors Know

02:45pm, Tuesday, 19'th Apr 2022 The Motley Fool
Abbott's innovation and execution drive long-term success despite many moving parts.
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

01:20pm, Monday, 18'th Apr 2022 Zacks Investment Research
Excluding COVID testing sales, Abbott's (ABT) worldwide Diagnostic sales are expected to have demonstrated strong growth in Q1 on the continuous rollout of Alinity, Abbott's suite of diagnostic instru
Before markets opened on Monday, Bank of America reported first-quarter results that beat both revenue and profit estimates, and shares traded up about 1%.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE